Dementia biomarkers -- phosphorylated tau (P-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) - ...

ESTHER study found that non-modifiable factors like age, sex, and APOE ε4 status significantly influence blood biomarker ...

Glial fibrillary acidic protein (GFAP) is a marker of astrocytic differentiation and is expressed in astroglial tumors. On the basis of the hypothesis that GFAP might be released from these tumors ...

Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread screening, a Karolinska Institutet study finds. A new study published in ...

Kinouchi et al. compared the outcome of retinal neuronal transplantation in wildtype mice with that in mice deficient in glial fibrillary acid protein (GFAP) and vimentin, two proteins that form the ...

4). Until a few years ago, analysis of lineage progression in this system was limited by a paucity of markers — only S100 calcium-binding protein (S100) and glial fibrillary acidic protein (GFAP ...

A long-term study reveals how age, sex, genetics, and menopause influence blood biomarkers related to dementia. The study ...

A new study, published in Nature Medicine, has investigated the potential of specific biomarkers such as tau217, Neurofilament Light (NfL), and Glial Fibrillary Acidic Protein (GFAP) to predict ...

Lifeforce, the world's leading longevity medicine program, has introduced the Lifeforce Brain Protection Program, a first-of-its-kind solution for people wanting to proactively take control of their ...